29 January 2020 in Nature
1 July 2012 in Journal of Molecular Biology
26 October 2022 in Nature Communications
The strict exchange of protons for sodium ions across cell membranes by Na+/H+exchangers is a fundamental mechanism for cell homeostasis. At active pH, Na+/H+exchange can be modelled as competition between H+and Na+to an ion-binding site, harbouring either one or two aspartic-acid residues. Nevertheless, extensive analysis on the model Na+/H+antiporter NhaA fromEscherichia coli, has shown that residues on the cytoplasmic surface, termed the pH sensor, shifts the pH at which NhaA becomes active. It was unclear how to incorporate the pH senor model into an alternating-access mechanism based on the NhaA structure at inactive pH 4. Here, we report the crystal structure of NhaA at active pH 6.5, and to an improved resolution of 2.2 Å. We show that at pH 6.5, residues in the pH sensor rearrange to form new salt-bridge interactions involving key histidine residues that widen the inward-facing cavity. What we now refer to as a pH gate, triggers a conformational change that enables water and Na+to access the ion-binding site, as supported by molecular dynamics (MD) simulations. Our work highlights a unique, channel-like switch prior to substrate translocation in a secondary-active transporter.
11 January 2016 in Proceedings of the National Academy of Sciences
NBNavisraj Balagunaseelan
+3
Significance: Microsomal prostaglandin E 2 synthase type 1 (mPGES-1) is an integral membrane protein that produces prostaglandin E 2 (PGE 2 ), a mediator of inflammation, fever, pain, and tumorigenesis. Here we show that a serine residue implicated by the crystal structure is not required for function, whereas an arginine and aspartate residue in the active site, observed to be interacting within the crystal structure, are essential and mutually dependent during catalysis. We also demonstrate that a contact signaling network can interrupt the arginine–asparagine interaction and facilitate their participation in the chemical mechanism. Our work has broad implications for development of effective mPGES-1 inhibitors, potential drugs with clinical application in treatment of inflammatory diseases and cancer.
1 February 2011 in Journal of Biological Chemistry
The polymorphic deletion of Glu-155 from human glutathione transferase omega1 (GSTO1-1) occurs in most populations. Although the recombinant Delta Glu-155 enzyme expressed in Escherichia coli is active, the deletion causes a deficiency of the active enzyme in vivo. The crystal structure and the folding/unfolding kinetics of the Delta Glu-155 variant were determined in order to investigate the cause of the rapid loss of the enzyme in human cells. The crystal structure revealed altered packing around the Glu-155 deletion, an increase in the predicted solvent-accessible area and a corresponding reduction in the buried surface area. This increase in solvent accessibility was consistent with an elevated Stern-Volmer constant. The unfolding of both the wild type and Delta Glu-155 enzyme in urea is best described by a three-state model, and there is evidence for the more pronounced population of an intermediate state by the Delta Glu-155 enzymes. Studies using intrinsic fluorescence revealed a free energy change around 14.4 kcal/mol for the wild type compared with around 8.6 kcal/mol for the Delta Glu-155 variant, which indicates a decrease in stability associated with the Glu-155 deletion. Urea induced unfolding of the wild type GSTO1-1 was reversible through an initial fast phase followed by a second slow phase. In contrast, the Delta Glu-155 variant lacks the slow phase, indicating a refolding defect. It is possible that in some conditions in vivo, the increased solvent-accessible area and the low stability of the Delta Glu-155 variant may promote its unfolding, whereas the refolding defect limits its refolding, resulting in GSTO1-1 deficiency.